PFA Intimation w.r.t Investor Call.
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajanta Pharma has informed BSE about an Earnings Conference Call scheduled for April 30, 2025 at 4:30 PM IST, to discuss its Q4 FY2025 audited financial results. The call will be hosted after the Board meeting on the same day and will include a Q&A session with the leadership team. International dial-in numbers have been provided for investors in the US, UK, Hong Kong, and Singapore, along with a Diamond Pass registration link for faster access. The company mentioned this is a re-upload as the earlier intimation was not visible on BSE. A transcript and audio playback will be made available on the company's website after the call.
This is a routine procedural announcement and is not expected to impact the stock price directly. However, investors should watch the Q4 FY2025 results and management commentary on the call for insights into the company's financial performance and outlook.